Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises

MT Newswires Live

Feb 26, 2025

Integral Diagnostics (ASX:IDX) reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.

Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.

Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.

The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.

The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.

Price (AUD): $2.86, Change: $-0.030, Percent Change: -1.04%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2514239540"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514239540\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2514239540?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-26 07:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514239540","market":"hk","top_or_hot":-1,"title":"Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises","media":"MT Newswires Live","content":"<html><body><p> Integral Diagnostics (ASX:IDX) reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.</p><p>Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.</p><p>Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.</p><p>The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.</p><p>The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.</p><p>Price (AUD): $2.86, Change: $-0.030, Percent Change: -1.04%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Integral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIntegral Diagnostics Fiscal H1 Loss Narrows as Revenue Rises\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-26 07:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Integral Diagnostics (ASX:IDX) reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.</p><p>Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.</p><p>Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.</p><p>The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.</p><p>The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.</p><p>Price (AUD): $2.86, Change: $-0.030, Percent Change: -1.04%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IDX.AU","symbol_name":"INTEGRAL DIAGNOSTICS LTD","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2514239540","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514239540","pubTimestamp":1740525720,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Integral Diagnostics  reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.Price : $2.86, Change: $-0.030, Percent Change: -1.04%","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"IDX.AU":"INTEGRAL DIAGNOSTICS LTD","INTEU":"Integral Acquisition Corporation 1"},"translate_title":"随着收入增长，Integral Diagnostics上半年亏损收窄","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IDX.AU":0.9,"INTEU":1},"content_text":"Integral Diagnostics (ASX:IDX) reported Wednesday attributable loss per diluted share in the fiscal first half narrowed to AU$0.0016, from a loss of AU$0.2862 per diluted share a year earlier.Analysts polled by Visible Alpha were expecting earnings per share of AU$0.0006.Revenue from ordinary activities for the six months Dec. 31, 2024, was AU$252.9 million, up 9% from AU$231.3 million in the same period last year. Analysts surveyed by Visible Alpha expected AU$250.6 million.The radiologist and diagnostic imaging provider replacement and growth capital expenditure for the fiscal year to reach AU$60 million to AU$65 million.The board declared an interim dividend of AU$0.025 per share, unchanged from the previous reported period, payable on April 7 to shareholders on record as of March 7.Price (AUD): $2.86, Change: $-0.030, Percent Change: -1.04%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}